Beam preps FDA run for industry-first base-edited therapy after pivotal sickle cell success
Beam Therapeutics’ cell therapy risto-cel freed patients with sickle cell disease from severe pain crises for at least one year,…
Beam Therapeutics’ cell therapy risto-cel freed patients with sickle cell disease from severe pain crises for at least one year,…